Medicine and Dentistry
Patient
86%
Cohort Analysis
68%
Bacteremia
40%
Venous Thromboembolism
36%
Inpatient
32%
Hospital
30%
Mortality
28%
Therapeutic Procedure
21%
Atrial Fibrillation
20%
Diagnosis
19%
Staphylococcal Bacteremia
16%
Hazard Ratio
16%
Incidence
15%
Age
14%
Bloodstream Infection
13%
Diseases
13%
Cohort Effect
12%
Anticoagulation
11%
Malignant Neoplasm
11%
Antithrombotic
11%
Arteriosclerosis Obliterans
9%
Abdominal Aortic Aneurysm
9%
Candidemia
9%
Blood Culture
9%
Apoplexy
8%
Mortality Rate
8%
Development
8%
Bleeding
7%
Comorbidity
7%
ICD-10
7%
Revascularization
6%
Health
6%
Anticoagulant Therapy
6%
Invasive Procedure
6%
Assessment
6%
Female
6%
Odds Ratio
6%
Person
5%
Morbidity
5%
Prognosis
5%
Adolescent
5%
Diabetes
5%
Life
5%
Cancer Staging
5%
Warfarin
5%
Disease
5%
Woman
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Venous Thromboembolism
29%
Diseases
21%
Case-Control Study
13%
Anticoagulant Agent
11%
Direct Oral Anticoagulant
10%
Bacteremia
10%
Atrial Fibrillation
9%
Staphylococcal Bacteremia
9%
Mortality
8%
Rivaroxaban
7%
Malignant Neoplasm
6%
Survival
6%
Warfarin
6%
Candidemia
6%
Antibiotics
6%
Anticoagulation Therapy
5%
Antiplatelet
5%
Nursing and Health Professions
Patient
19%
Cohort Analysis
16%
Bacteremia
16%
Venous Thromboembolism
16%
Cancer Registry
13%
Hospital
10%
Cancer Staging
9%
Neoplasm
7%
Confidence Interval
6%
Metastasis
6%
Patient with Cancer
6%
Length of Stay
6%
Hospital Readmission
6%
Control
5%